Stonegate Capital Partners Updates Coverage on Provident Financial Services Inc (NYSE: PFS) 1Q26
Provident Financial Services delivered a steady 1Q26, with the post-Lakeland profitability profile holding despite lower q/q EPS and a more visible credit watch item. Net income was $79.4M, or $0.61 diluted EPS, versus $83.4M, or $0.64, in 4Q25, while ROAA was 1.29%, Pre-provision net-revenue ROAA was 1.75%, and ROATCE was 16.58%. Revenue remained above $225M […]
Stonegate Updates Coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM) Q126
NCSM’s 1Q26 came in below expectations as Canada and select international projects weighed on results, while continued U.S. momentum helped offset the shortfall. In our view, the quarter does not change the core thesis around U.S. product momentum, ResMetrics integration, and the Company’s capital-light model, but it does highlight the timing risk embedded in Canada […]
Stonegate Capital Partners Updates Coverage on Vinte Viviendas Integrales (BMV: VINTE) 1Q26
Management’s 1Q26 message centered on scaling the larger Vinte/Javer/Derex platform with tighter capital allocation, continued integration, and margin expansion rather than pursuing growth at the expense of returns. The release also reinforced management’s focus on generating ROIC above its cost of capital and on leveraging adjacent business lines and PropTech capabilities alongside the core housing […]
Stonegate Updates Coverage on Third Coast Bancshares, Inc. (NYSE: TCBX) 1Q26
For 1Q26, Third Coast reported net income of $16.4M, or $1.03/$0.88 basic/diluted EPS, versus $17.9M and $1.21/$1.02 in 4Q25. The linked-quarter decline was primarily driven by approximately $3.3M of pre-tax Keystone-related merger expense, including elevated legal/professional fees and higher compensation tied to retention, sign-on, and discretionary bonuses. Even with that noise, profitability remained solid, with […]
Stonegate Capital Partners Updates Coverage on Armour Residential REIT, Inc. (NYSE: ARR) Q126
ARR reported a net loss available to common shareholders of $(58.0)M, or $(0.49)/share, as stronger carry income was more than offset by quarter-end mark-to-market pressure across the portfolio. Net interest income improved to $70.7M, but this was outweighed by a $(182.6)M loss on Agency securities and a $(10.6)M loss on U.S. Treasuries, partially offset by […]
Stonegate Updates Coverage on Hooker Furniture Corporation (NASDAQ: HOFT) 4Q26
HOFT reported revenue, operating income, and adj EPS of $67.0M, $0.6M, and $0.05, respectively. This compares to our/consensus estimates of $77.1M/$74.1M, $1.6M/$1.0M, and $0.09/$0.05. For the quarter, HOFT reported revenue of $67.0M, down 20.5% y/y, driven by a one-week shorter period, lower hospitality shipments, and an estimated $3M-$4M of January weather disruption. Despite the weaker […]
Stonegate Capital Partners Updates Coverage On GoHealth Inc. (NASDAQ: GOCO) 4Q25
GoHealth’s 4Q25 results continued to reflect a Medicare Advantage environment shaped by tighter carrier discipline, with management prioritizing retention, member quality, and liquidity over volume. FY25 net revenue was $361.8M, implying a materially lower 4Q25 revenue base y/y as the intentional Medicare Advantage pullback continued through AEP. Management reiterated that carriers remain focused on margin […]
Stonegate Capital Partners Updates Coverage on Seabridge Gold Inc. (NYSE: SA) 4Q25
Seabridge Gold (“SA”) is a North American gold-copper developer anchored by KSM, one of the largest undeveloped gold-copper projects globally. The Company’s strategy is to maximize per-share value by advancing large-scale assets to a partner-ready stage and monetizing via joint venture, rather than self-funding multi-billion-dollar mine builds. At ~$3–4B market cap, SA appears to meaningfully […]
Stonegate Capital Partners Initiates Coverage on Pedevco Corp. (NYSE: PED)
PEDEVCO exited FY25 as a much larger, oil-weighted Rockies platform following the Juniper merger. For FY25, production increased 35% y/y to 910.1 Mboe (2,494 Boe/d), revenue rose 16% to $45.8M, and adjusted EBITDA increased 18% to $27.0M despite a 19% decline in realized crude oil prices. Reported earnings moved to a net loss of $(10.4)M […]
Stonegate Capital Partners Updates Coverage on Cingulate Inc. (NASDAQ: CING) 4Q25
Stonegate Capital Partners updates their coverage on Cingulate Inc. (NASDAQ: CING). Cingulate’s 4Q25 update continues to position CTx-1301 toward a potential commercial ADHD launch, with the regulatory focus now centered on manufacturing (CMC) rather than clinical performance. The NDA remains under FDA review under the 505(b)(2) pathway, and recent financing, IP progress, and commercial buildout efforts remain supportive of […]